Imagen de Portada

AI-Driven Multi-Targeted Phytochemical Formulation for Prostate Cancer Prevention and Support: A Theoretical Framework for Research

Fuente: Zenodo

Guardado en:

Detalles Bibliográficos
Autor principal:	Landry, Marie Seshat
Formato:	Recurso digital
Publicado:	Zenodo 2025
Materias:	Prostate cancer Phytochemicals
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Herbal Bioactive Targeting Prostate Cancer: A Network Pharmacology and Molecular Mechanism Perspective
por: Shubham Patil1, Ashok Bendgude2, Siddhi Shirahatti3, Ajit Patil4, Godfrey Mathews5
Publicado: (2026)

Comparative antiproliferation of human prostate cancer cells by ethanolic extracts of two groups of Brazilian propolis
por: Cleber Silveira MORAES
Publicado: (2010)

Prostate cancer patient’s survival in Lithuania
por: Giedrė Smailytė
Publicado: (2012)

¿ Existe el cáncer localizado de próstata?
por: Bernard LOBEL MANDEL
Publicado: (2005)

Cáncer de Próstata. ¿Qué es el antígeno prostático específico?. (La biología del PSA)
por: Juan Fernando Uribe Arcila
Publicado: (2007)

Molecular Docking Analysis of Liliaceae Family Phytochemicals to Estrogen Receptor α on Breast Cancer Compared to Genistein
por: Permana, Bryan, et al.
Publicado: (2015)

Prostate-specific antigen in men from the municipality of Paipa, Boyacá 2016
por: Angela Liliana Monroy Díaz
Publicado: (2018)

Incidence of adenocarcinoma in the transitional zone of the prostate in a public institution. Cochabamba, Bolivia
por: Javier Ferrufino Iriarte
Publicado: (2020)

Prostate cancer mortality according to marginalization status in Mexican states from 1980 to 2013
por: Luisa E Torres-Sánchez
Publicado: (2016)

Zinc concentrations in the expressed prostatic fluid of patients with bladder cancer
por: Vladimir Zaichick
Publicado: (2020)

The role of different PI-RADS versions in prostate multiparametric magnetic resonance tomography assessment
por: Paulius Aliukonis
Publicado: (2017)

Changes in prostate cancer incidence in 50–75-year-old men in Lithuania 2006–2009: effect of early diagnosis program
por: Robertas Adomaitis
Publicado: (2011)

Oncological outcomes of surgery in very high risk pT3b prostate cancer
por: Daimantas Milonas
Publicado: (2011)

Dosimetric effectiveness in implants with distinct Ho-166 seed distributions in a prostate model
por: Viviane Vitória Bento Braga
Publicado: (2019)

The first clinical experience in prostate cancer salvage cryotherapy
por: Ulys Albertas
Publicado: (2013)

Genetics‐Driven, Intensity‐Modulated Adaptive Management of Patients With Metastatic Prostate Cancer
por: Reynier D. Rodriguez Rosales, et al.
Publicado: (2025)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
por: Elizabeth Robinson, et al.
Publicado: (2025)

Providing a Prostate Cancer Detection and Prevention Method With Developed Deep Learning Approach
por: Alireza Zarei, et al.
Publicado: (2025)

Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
por: Yuto Ono, et al.
Publicado: (2025)

Harnessing Phytochemicals for Brain Cancer Therapy: Insights Into Medulloblastoma and Glioblastoma Treatment
por: Ilkay Irem Ozbek, et al.
Publicado: (2026)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
por: Tatsuya Shimomura, et al.
Publicado: (2026)

Evidence and Rationale for Prostate Cancer Screening
por: Takeshi Takahashi
Publicado: (2025)

First experience of salvage HDR brachytherapy after prostate cancer radiotherapy
por: Juras Kišonas
Publicado: (2014)

Molecular analysis of multifocal prostate cancer cases
por: Rasa Sabaliauskaitė
Publicado: (2011)

Altered Glycosylation of PSA in Prostate Cancer Tissue
por: Hannu Koistinen, et al.
Publicado: (2025)

Castration Resistance Accelerates Prostate Cancer Kinetics
por: Sheila Jonnatan, et al.
Publicado: (2026)

CHARGE: The “Big Questions” in Prostate Cancer for 2024
por: Andrea K. Miyahira, et al.
Publicado: (2024)

Integrating Clinical and Societal Perspectives on Prostate Cancer Research: Addressing Key Limitations and Future Directions
por: Yuekun Fang, et al.
Publicado: (2026)

Current Status of Prostate Biopsy in Africa: Are We Ready for a Targeted Biopsy?
por: Ziba Ouima Justin Dieudonne, et al.
Publicado: (2025)

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models
por: Haotian Chen, et al.
Publicado: (2025)

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
por: Yifu Shi, et al.
Publicado: (2025)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
por: Cameron J. Britton, et al.
Publicado: (2025)

Developments in Ultrasound‐Based Imaging for Prostate Cancer Detection
por: Reid Vassallo, et al.
Publicado: (2025)

Factors Associated With Male Breast Cancer Incidence Among Prostate Cancer Survivors: Real World Evidence From Veterans Affairs National Prostate Cancer Data Core
por: Erum Z. Whyne, et al.
Publicado: (2025)

Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
por: Charly Bâcle, et al.
Publicado: (2025)

Spatial Distribution of Prostate Cancer Missed by MRI‐Targeted Biopsy, Effect of a Perilesional Template, and Restaging in a Radical Prostatectomy Cohort
por: Ruth Himmelsbach, et al.
Publicado: (2026)

Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes
por: Christian P. Pavlovich, et al.
Publicado: (2025)

Spatial Robustness of Prostate Cancer Biomarkers Evaluated by Spatial Transcriptomics
por: Kristofer G. Taylor, et al.
Publicado: (2026)

Comprehensive Analysis of Fraction of Genome Altered in Prostate Cancer Treatment
por: Muhammad Umair, et al.
Publicado: (2026)

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide
por: Christian Andrés Martínez Osorio, et al.
Publicado: (2025)